Literature DB >> 17507091

Idiopathic cytopenia of undetermined significance (ICUS) versus low risk MDS: the diagnostic interface.

Friedrich Wimazal1, Christa Fonatsch, Renate Thalhammer, Ilse Schwarzinger, Leonhard Müllauer, Wolfgang R Sperr, John M Bennett, Peter Valent.   

Abstract

It may sometimes be difficult to diagnose low risk MDS in patients with mild cytopenia. We report on 10 patients with mild to marked, unexplained cytopenia without definitive signs of a myeloid neoplasm. In two patients, a karyotype-abnormality (trisomy 14; monosomy 7) was detected in a small subset of bone marrow cells. Progression to overt MDS was seen in two patients including the one with monosomy 7. In the remaining cases, no MDS developed in a follow-up of at least 6 months. The phrase "idiopathic cytopenia of undetermined significance (ICUS)", as also suggested by Mufti and co-workers, is proposed and long term follow-up is recommended to assess the evolution.

Entities:  

Mesh:

Year:  2007        PMID: 17507091     DOI: 10.1016/j.leukres.2007.03.015

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  25 in total

1.  Idiopathic bone marrow dysplasia of unknown significance (IDUS): definition, pathogenesis, follow up, and prognosis.

Authors:  Peter Valent; Eva Jäger; Gerlinde Mitterbauer-Hohendanner; Leonhard Müllauer; Ilse Schwarzinger; Wolfgang R Sperr; Renate Thalhammer; Friedrich Wimazal
Journal:  Am J Cancer Res       Date:  2010-03-16       Impact factor: 6.166

Review 2.  How we diagnose neutropenia in the adult and elderly patient.

Authors:  Jan Palmblad; Carlo Dufour; Helen A Papadaki
Journal:  Haematologica       Date:  2014-07       Impact factor: 9.941

3.  Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes.

Authors:  Peter L Greenberg; Heinz Tuechler; Julie Schanz; Guillermo Sanz; Guillermo Garcia-Manero; Francesc Solé; John M Bennett; David Bowen; Pierre Fenaux; Francois Dreyfus; Hagop Kantarjian; Andrea Kuendgen; Alessandro Levis; Luca Malcovati; Mario Cazzola; Jaroslav Cermak; Christa Fonatsch; Michelle M Le Beau; Marilyn L Slovak; Otto Krieger; Michael Luebbert; Jaroslaw Maciejewski; Silvia M M Magalhaes; Yasushi Miyazaki; Michael Pfeilstöcker; Mikkael Sekeres; Wolfgang R Sperr; Reinhard Stauder; Sudhir Tauro; Peter Valent; Teresa Vallespi; Arjan A van de Loosdrecht; Ulrich Germing; Detlef Haase
Journal:  Blood       Date:  2016-08-17       Impact factor: 22.113

4.  Are mild/moderate acquired idiopathic aplastic anaemia and low-risk myelodysplastic syndrome one or two diseases or both and how should it/they be treated?

Authors:  S Nakao; R P Gale
Journal:  Leukemia       Date:  2016-09-02       Impact factor: 11.528

5.  MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance.

Authors:  Brian Kwok; Jeff M Hall; John S Witte; Yin Xu; Prashanti Reddy; Keming Lin; Rachel Flamholz; Bashar Dabbas; Aine Yung; Jenan Al-Hafidh; Emily Balmert; Christine Vaupel; Carlos El Hader; Matthew J McGinniss; Shareef A Nahas; Julie Kines; Rafael Bejar
Journal:  Blood       Date:  2015-10-01       Impact factor: 22.113

Review 6.  Dysplasia has A differential diagnosis: distinguishing genuine myelodysplastic syndromes (MDS) from mimics, imitators, copycats and impostors.

Authors:  David P Steensma
Journal:  Curr Hematol Malig Rep       Date:  2012-12       Impact factor: 3.952

Review 7.  New strategies in myelodysplastic syndromes: application of molecular diagnostics to clinical practice.

Authors:  Zuzana Tothova; David P Steensma; Benjamin L Ebert
Journal:  Clin Cancer Res       Date:  2013-01-17       Impact factor: 12.531

Review 8.  Clonal hematopoiesis in acquired aplastic anemia.

Authors:  Seishi Ogawa
Journal:  Blood       Date:  2016-04-27       Impact factor: 22.113

9.  Idiopathic Fatal Pancytopenia: A Case Report.

Authors:  Hema Goyal; Vijai Tilak
Journal:  J Clin Diagn Res       Date:  2016-06-01

10.  Distinguishing immunorelated haemocytopenia from idiopathic cytopenia of undetermined significance (ICUS): a bone marrow abnormality mediated by autoantibodies.

Authors:  R Fu; H Liu; Y Wang; H Liu; H He; J Chen; H Wang; H Yu; K Ding; L Huang; H Wang; L Xing; J Song; L Li; Z Shao
Journal:  Clin Exp Immunol       Date:  2014-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.